BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23175469)

  • 21. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system.
    Qian X; Agematsu K; Freeman GJ; Tagawa Y; Sugane K; Hayashi T
    Eur J Immunol; 2006 Apr; 36(4):906-18. PubMed ID: 16552709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans.
    Salih HR; Wintterle S; Krusch M; Kroner A; Huang YH; Chen L; Wiendl H
    Exp Hematol; 2006 Jul; 34(7):888-94. PubMed ID: 16797416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1.
    Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H
    Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.
    Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H
    Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone.
    Kato T; Morokata T; Igarashi O; Yee ST; Inobe M; Uede T; Azuma M; Okumura K; Nariuchi H
    Cell Immunol; 1997 Feb; 176(1):50-8. PubMed ID: 9070317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.
    Norde WJ; Maas F; Hobo W; Korman A; Quigley M; Kester MG; Hebeda K; Falkenburg JH; Schaap N; de Witte TM; van der Voort R; Dolstra H
    Cancer Res; 2011 Aug; 71(15):5111-22. PubMed ID: 21659460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct.
    Matulonis U; Dosiou C; Freeman G; Lamont C; Mauch P; Nadler LM; Griffin JD
    J Immunol; 1996 Feb; 156(3):1126-31. PubMed ID: 8557988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes.
    Banat GA; Usluoglu N; Hoeck M; Ihlow K; Hoppmann S; Pralle H
    Br J Haematol; 2004 Aug; 126(4):593-601. PubMed ID: 15287954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
    Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
    Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
    Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
    Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O; Ulvestad E
    Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
    Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
    Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of costimulatory molecules in human leukemias.
    Hirano N; Takahashi T; Takahashi T; Ohtake S; Hirashima K; Emi N; Saito K; Hirano M; Shinohara K; Takeuchi M; Taketazu F; Tsunoda S; Ogura M; Omine M; Saito T; Yazaki Y; Ueda R; Hirai H
    Leukemia; 1996 Jul; 10(7):1168-76. PubMed ID: 8683998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
    Agrewala JN; Suvas S; Verma RK; Mishra GC
    J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7.
    Damle NK; Linsley PS; Ledbetter JA
    Eur J Immunol; 1991 May; 21(5):1277-82. PubMed ID: 1645270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
    Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
    Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.